Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Application
6.1 Stents
6.1.1 Self-expandable stents
6.1.2 Covered Stents
6.1.3 Balloon expandable stent
6.2 Angioplasty Balloons
6.2.1 Based on material used
6.2.1.1 Semi-Compliant Balloons
6.2.1.2 Non-Compliant Balloons
6.2.2 Based on product
6.2.2.1 Cutting balloon
6.2.2.2 Normal balloon
6.2.2.3 Drug Coated balloon
6.2.2.4 Scoring balloon
6.3 Inferior Vena Cava filters
6.4 Embolic Protection devices
6.5 Aortic Stent Grafts
6.6 Peripheral Vascular Accessory Devices
6.7 PTA Balloon Catheters
6.8 Synthetic Surgical Grafts
6.9 Chronic Total Occlusion (CTO) Devices
6.10 Vascular Closure Devices
6.11 Others
Chapter 7 Market Segmentation by Geography
7.1 Asia Pacific
7.1.1 Introduction
7.1.2 China
7.1.3 India
7.1.4 Japan
7.1.5 Australia & New Zealand
7.1.6 Others
7.2 North America
7.2.1 Introduction
7.2.2 United States
7.2.3 Canada
7.2.4 Mexico
7.2.5 Others
7.3 Europe
7.3.1 Introduction
7.3.2 Spain
7.3.3 UK
7.3.4 France
7.3.5 Russia
7.3.6 Italy
7.3.7 Others
7.4 The Middle East and Africa
7.4.1 Introduction
7.4.2 South Africa
7.4.3 Middle East Countries
7.4.4 Others
7.5 South America
7.5.1 Introduction
7.5.2 Argentina
7.5.3 Brazil
7.5.4 Others
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Market Share Analysis
8.3 Strategies Adopted By Top Companies
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Business Overview
9.1.2 Product portfolio
9.1.3 Key Strategy
9.1.4 Recent Developments
9.2 Angioscore
9.3 C.R.Bard, Inc.
9.4 Boston Scientific Corporation
9.5 Biosensors International Group
9.6 Bayer AG
9.7 Emboline INC
9.8 Covidien PLC
9.9 Lombard Medical Technologies Plc
9.10 Ednologix
9.11 Edward Lifesciences Corporation
9.12 Volcano Corporation
9.13 Cordis Corporation
9.14 Terumo Interventional Systems Inc.
9.15 Bayer
Chapter 10 Market Estimates and Forecast
10.1 Market Estimates and Forecast 2018-2024(USD Million)
10.1.1 Market Estimation and Forecast by Application 2018-2024 (USD Million)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
